Dr. Rebecca Manno of the Johns Hopkins Arthritis Center discusses exercise, joint damage and flares in arthritis patients.
Rheumatoid Arthritis News
OTREXUP™ (methotrexate) injection was recently approved by the U.S. Food and Drug Administration.
It is indicated for adults with severe, active rheumatoid arthritis, or children with active polyarticular juvenile idiopathic arthritis who have failed first line therapies. It is also indicated for severe, recalcitrant, disabling psoriasis.